Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-26-017064
Filing Date
2026-05-14
Accepted
2026-05-14 16:17:02
Documents
75
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q eton20260331_10q.htm   iXBRL 10-Q 948770
2 EXHIBIT 10.1 ex_951829.htm EX-10.1 251792
3 EXHIBIT 31.1 ex_912394.htm EX-31.1 8725
4 EXHIBIT 31.2 ex_912395.htm EX-31.2 8725
5 EXHIBIT 32.1 ex_912396.htm EX-32.1 6332
11 hasig.jpg GRAPHIC 2614
12 magsig.jpg GRAPHIC 3067
13 sbsig.jpg GRAPHIC 2556
  Complete submission text file 0001437749-26-017064.txt   6529046

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA eton-20260331.xsd EX-101.SCH 59521
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eton-20260331_cal.xml EX-101.CAL 37466
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eton-20260331_def.xml EX-101.DEF 415382
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE eton-20260331_lab.xml EX-101.LAB 369471
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eton-20260331_pre.xml EX-101.PRE 447399
79 EXTRACTED XBRL INSTANCE DOCUMENT eton20260331_10q_htm.xml XML 927702
Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278 (847) 787-7361
Eton Pharmaceuticals, Inc. (Filer) CIK: 0001710340 (see all company filings)

EIN.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38738 | Film No.: 26979209
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)